Delivering the best outcome

for your clinical studies

We take pride in becoming an extension of your team to help you overcome some of the biggest human health challenges.

The Australian advantage

Speed, Quality and Cost-effectiveness

Experienced network of CROs, data generated is FDA, EMA compliant – accepted for Phase 2 & 3 studies conducted globally.

The Australian Regulatory Framework: CTN scheme 4-8 weeks for review, less than 12 weeks for study start-up.

No requirement for IND.

The R&D Tax Incentive: 43.5% cash back for every $ spent in R&D in Australia, available to international and national sponsors.

Victoria is a recognised leader in early stage clinical trials, known for the quality of its clinical sites and the clinician expertise that facilitates the timely execution of excellent clinical trials.

Quality Standards

Our Quality Focus

Veracity Biolabs offers services to the highest industry standards.

Veracity Biolabs is proud of the quality and consistency of the tests and data generated on behalf of our sponsors.

Through the combined expertise of our team and partner NATA accredited laboratories we offer a broad portfolio of products and services including:

Tailored assay development and qualification or validation according to international regulatory ICH, FDA and EMA guidelines, industry standards, and project specific requirements.

Validated ISO17025 and ISO15189 routine and complex assays.

Access to BSL3 and BSL4 cutting edge facilities.